Molina Choummanivong, LaosUniversity of Health Sciences Faculty of Public Health
Author Of 1 Presentation
COMMUNICATING PCV13 IMPACT RESULTS IN LAO PDR, USING A MULTIMEDIA APPROACH (ID 690)
- Shereen Labib, Australia
- Jocelyn Chan,
- Keoudomphone Vilivong, Laos
- Mimee Laddaphone, Laos
- Jana Y. Lai, Australia
- Lauren Franzel-Sassanpour, Laos
- Eileen M. Dunne, United States of America
- Paul N. Newton, United Kingdom
- Kim E. Mulholland, Australia
- Audrey Dubot-Pérès, Laos
- Catherine Satzke, Australia
- Molina Choummanivong, Laos
- Vanphanom Sychareun, Laos
- Anonh Xeuatvongsa, Laos
- Mayfong Mayxay, United Kingdom
- David A. Dance, Laos
- Fiona M. Russell, Australia
In 2013, Lao PDR introduced PCV13 with Gavi support. WHO requested a PCV13 impact evaluation as the Ministry of Health required evidence of PCV13 impact. Our project included a variety of community and hospital-based carriage and disease studies.
We partnered with Lao Ministry of Health and WHO, the key end-users, from the outset. We performed high quality research by collaborating with established international research institutions in Laos, the Lao Oxford Mahosot Hospital-Wellcome Trust Research Unit (LOMWRU) and the leading Lao medical university, The University of Health Sciences, to undertake the research. We developed an infographic and a video of the results.
We disseminated our results to immunisation policy makers at the Lao Ministry of Health, WHO (Laos office and Geneva) and our funders, Gavi, the Vaccine Alliance, and the Bill & Melinda Gates Foundation. Our results were presented to the Lao paediatricians and NITAG members; and at various local, regional and international conferences. The Laos Minister of Health presented the findings to the Gavi Board. The video and infographic were launched on social media and hosted on our institutions’ (MCRI and University of Melbourne) webpage, to coincide with World Pneumonia Day.
This multipronged approach ensured wide dissemination of findings.